COVID-19 Immunity Task Force

From Wikipedia, the free encyclopedia

The COVID-19 Immunity Task Force (CITF) is one of the Government of Canada's early efforts to track the 2020 coronavirus pandemic.[1] An external, dedicated secretariat will help maximize the efficiency of the CITF's work.[2]

Task Force membership[]

The CITF Board is composed of doctors, infectious disease experts, and policy makers. Its charter members were five:[1]

  • David Naylor
  • Theresa Tam
  • Catherine Hankins
  • Mona Nemer

The CCITF board expanded on 2 May 2020. Its additional members are:[3]

Purpose and goals[]

The CITF was to use a serology "to survey representative samples of the population for the presence of antibodies to the virus".[4] Trudeau's press release on 23 April 2020, on the initiation of the CCITF listed several goals it would help to achieve notably that it would:[2]

establish priorities and oversee the coordination of a series of country-wide blood test surveys that will tell us how widely the virus has spread in Canada and provide reliable estimates of potential immunity and vulnerabilities in Canadian populations.

References[]

  1. ^ a b "WHO set pandemic response back by 2-3 weeks, says doctor on new federal task force". CBC. 23 April 2020.
  2. ^ a b "Prime Minister announces new support for COVID-19 medical research and vaccine development". Justin Trudeau, Prime Minister of Canada. 23 April 2020.
  3. ^ Letterhead of CCITF: List of Members - CCITF Leadership Group (Tweet photo from C. David Naylor)
  4. ^ "Canada launches serological testing initiative to help manage COVID-19". McGill University Institutional Communications. 23 April 2020.

External links[]


Retrieved from ""